BORTLIEVA (BORTEZOMIB INJECTION IP 3.5MG /VIAL -

USD
- INR
- EUR
- - Buyer
    
    Register as a Foriegn Buyer
  - Seller
    
    Log In Register as a Seller

Get Quotations List Products

BORTLIEVA (BORTEZOMIB INJECTION IP 3.5MG /VIAL

ITC-HSN: 30049095

Price on Request

Min Order Qty 1 Piece

Product not available

Bortezomib Injection IP 3.5mg

Brand Name BORTELIEVA 3.5MG

Composition Bortezomib Injection IP 3.5mg

Manufacture By Allieva Pharma Private Limited

Form Injection

Packing Vial

Country Of Origin India ANTI CANCER MEDICINE USE IN ONCOLOGY PRESCRIPTION DRUGS SCHEDUED DRUGS

Prescription Required

RADHAKRUSHNA MEDICALS

Yavatmal, India

Business Operations: Merchant

Contact Seller

Share on:

Agency Request
Distributorship Request
Contract Manufacturing
Joint Venture
Buying Agents
Importers
Business Development Agencies

By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

Description
Business Information

Description

BORTLIEVA contains Bortezomib, a proteasome inhibitor used in cancer treatment. It works by blocking proteasomes in cells, leading to accumulation of proteins and apoptosis (cell death) of cancer cells.

Uses

Bortezomib is used in adults for:

1. Multiple myeloma

– Newly diagnosed or relapsed/refractory

2. Mantle cell lymphoma

– Previously treated patients

3. Sometimes in combination with other chemotherapies for certain hematologic cancers.

Side Effects

Common side effects:

• Fatigue, weakness

• Peripheral neuropathy (tingling/numbness)

• Nausea, vomiting

• Diarrhea or constipation

• Low blood counts (thrombocytopenia, neutropenia)

Serious side effects:

• Severe infections

• Severe neuropathy

• Heart problems (rare)

• Liver function abnormalities

Monitor blood counts and liver function regularly.

Dosage

• 1.3 mg/m² IV or SC on Days 1, 4, 8, 11 of a 21-day cycle (common regimen)

• Dose may be adjusted based on side effects or prior therapies

• Can be given intravenously (IV) or subcutaneously (SC)

NOTE: This medicine should be taken only under a doctor’s supervision.

Established in:	2021
Bussiness Type:	Sole Proprietorship
Bussiness Type:	Merchant
MSME:	Yes
Countries exporting to:	United States, Philippines, Smaller Territories of the UK, United Kingdom, Bangladesh, Pakistan, Nepal, United Arab Emirates, Australia, Malaysia, Canada, Korea North, Korea South, Thailand, Mexico, Saudi Arabia, Bulgaria, Russia, Poland, Ethiopia, Zimbabwe, Taiwan, Albania, Azerbaijan, Brazil, Tanzania, Bhutan, France, Kuwait, Egypt, Vietnam, Belgium, Belarus, Congo, Czech Republic, Germany, Greece, Greenland, Indonesia, Iran, Israel, Italy, Japan, Jordan, Kenya, Latvia, Lebanon, Liberia, Lithuania, Macedonia, Afghanistan
Export Turnover (3 years):	US$10,000 to US$50,000
Countries would like to export to:	Austria, United States, United Kingdom, Turkey, Thailand, Switzerland, Sri Lanka, South Africa, Bangladesh, Albania, American Samoa, Anguilla, Malaysia, Canada, Korea North, Japan, Korea South, Uzbekistan, Azerbaijan, Bhutan, Belgium, Australia, Afghanistan, Mexico, France, Ethiopia, Germany, Netherlands Antilles, Tanzania, Turks And Caicos Islands, Italy, Bulgaria, Greece, Greenland, Indonesia, Iran, Iraq, Congo, Latvia, Lebanon, Liberia, Lithuania, Kenya, Central African Republic, United Arab Emirates, Philippines, Algeria, Andorra
No of employees:	1-10

BORTLIEVA (BORTEZOMIB INJECTION IP 3.5MG /VIAL

Related Products

BORTENAT INJ 3.5MG

Bortenat 2mg

Artesunate Injection 60 mg

BORTENAT INJ 2.0MG

Injection Plastic Moulds

ETAMSYLATE B.P. (TABLET & INJECTION GRADE)

Injection Molded Pallet

INJECTION PACKERS 150MM

INJECTION PACKERS 75MM

INJECTION PACKERS 100MM

INJECTION PACKERS 200MM

Injection Mould